Design, expression, and characterization of a novel targeted plectasin against methicillin-resistant Staphylococcus aureus

Applied Microbiology and Biotechnology

Volumn 97, Issue 9, 2013, Pages 3991-4002

  Mao, Ruoyu ^a,b   Teng, Da ^a,b   Wang, Xiumin ^a,b   Xi, Di ^a,b   Zhang, Yong ^a,b   Hu, Xiaoyuan ^a,b   Yang, Yalin ^a   Wang, Jianhua ^a,b  

^a AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Agplectasin; MRSA; Pichia pastoris; Plectasin; STAMP

Indexed keywords

BACTERIA; CHROMATOGRAPHY; HYDROPHOBIC CHROMATOGRAPHY; STAMPING; YEAST;

AGPLECTASIN; CATION EXCHANGE CHROMATOGRAPHY; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MINIMAL INHIBITORY CONCENTRATION; MRSA; PICHIA PASTORIS; PLECTASIN; STAPHYLOCOCCUS EPIDERMIDIS;

BLOOD;

AGPLECTASIN; BACTERIAL PROTEIN; PLECTASIN; UNCLASSIFIED DRUG; AGRD PROTEIN, STAPHYLOCOCCUS; ANTIINFECTIVE AGENT; CYCLOPEPTIDE; HYBRID PROTEIN; PEPTIDE;

ANTIBIOTICS; BACTERIUM; GENE EXPRESSION; MICROBIAL ACTIVITY; PEPTIDE; REACTION KINETICS; YEAST;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL VIABILITY; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE EXPRESSION; GENE STRUCTURE; GENE SYNTHESIS; HEMOLYSIS; HUMAN; HUMAN CELL; HYDROPHOBIC INTERACTION CHROMATOGRAPHY; ION EXCHANGE CHROMATOGRAPHY; KOMAGATAELLA PASTORIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR WEIGHT; NONHUMAN; PH; PROTEIN PURIFICATION; STAPHYLOCOCCUS EPIDERMIDIS; THERMOSTABILITY; DRUG EFFECT; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; PICHIA;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PICHIA PASTORIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; PEPTIDES; PEPTIDES, CYCLIC; PICHIA; RECOMBINANT FUSION PROTEINS;

EID: 84885936067     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-012-4508-z     Document Type: Article

References (52)

1. Bai X, Teng D, Tian Z, Zhu Y, Yang Y, Wang J (2010) Contribution of bovine lactoferrin inter-lobe region to iron binding stability and antimicrobial activity against Staphylococcus aureus. BioMetals 23:431-439
2. Boman HG (2000) Innate immunity and the normal microflora. Immunol Rev 173:5-16
3. Chambers HF (2001) The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 7:178-182
4. Chandler JR, Dunny GM (2004) Enterococcal peptide sex pheromones: synthesis and control of biological activity. Peptides 25:1377-1388
5. Cho J, Lee DG (2011) The characteristic region of arenicin-1 involved with a bacterial membrane targeting mechanism. Biochem Biophys Res Commun 405:422-427
6. Eckert R (2011) Road to clinical efficacy challenges and novel strategies for antimicrobial peptide development. Future Microbiol 6:635-651
7. Eckert R, Brady KM, Greenberg EP, Qi F, Yarbrough DK, He J, McHardy I, Anderson MH, Shi W (2006a) Enhancement of antimicrobial activity against Pseudomonas aeruginosa by co-administration of G10KHc and tobramycin. Antimicrob Agents Chemother 50:3833-3838
8. Eckert R, He J, Yarbrough DK, Qi F, Anderson MH, Shi W (2006b) Targeted killing of Streptococcus mutans by a pheromone-guided "smart" antimicrobial peptide. Antimicrob Agents Chemother 50:3651-3657
9. Franzman MR, Burnell KK, Dehkordi-Vakil FH, Guthmiller JM, Dawson DV, Brogden KA (2009) Targeted antimicrobial activity of a specific IgG-SMAP28 conjugate against Porphyromonas gingivalis in a mixed culture. Int J Antimicrob Agents 33:14-20
10. Gottlieb C, Thomsen L, Ingmer H, Mygind P, Kristensen HH, Gram L (2008) Antimicrobial peptides effectively kill a broad spectrum of Listeria monocytogenes and Staphylococcus aureus strains independently of origin, sub-type, or virulence factor expression. BMC Microbiol 8:205-214
11. Hanberger H, Walther S, Leone M, Barie PS, Rello J, Lipman J, Marshall JC, Anzueto A, Sakr Y, Pickkers P, Felleiter P, Engoren M, Vincent JL (2011) Increased mortality associated with meticillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study. Int J Antimicrob Agents 38:331-335
12. Hara S, Mukae H, Sakamoto N, Ishimoto H, Amenomori M, Fujita H, Ishimatsu Y, Yanagihara K, Kohno S (2008) Plectasin has antibacterial activity and no affect on cell viability or IL-8 production. Biochem Biophys Res Commun 374:709-713
13. Highlander SK, Xie Y, He Y, Gehring A, Hu Y, Li Q, Tu SI, Shi X (2011) Genotypes and toxin gene profiles of Staphylococcus aureus clinical isolates from china. PLoS One 6:e28276
14. Hsiao CH, Chuang CC, Tan HY, Ma DHK, Lin KK, Chang CJ, Huang YC (2012) Methicillin-resistant Staphylococcus aureus ocular infection: a 10-Year hospital-based study. Ophthalmology 119:522-527
15. Jarraud S, Lyon GJ, Figueiredo AMS, Gérard L, Vandenesch F, Etienne J, Muir TW, Novick RP (2000) Exfoliatin-producing strains define a fourth agr specificity group in Staphylococcus aureus. J Bacteriol 182:6517-6522
16. Ji G, Beavis RC, Novick RP (1995) Cell density control of staphylococcal virulence mediated by an octapeptide pheromone. Proc Natl Acad Sci USA 92:12055-10259
17. Jin T, Bokarewa M, Foster T, Mitchell J, Higgins J, Tarkowski A (2004) Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J Immunol 172:1169-1176
18. Jin F, Xu X, Wang L, Zhang W, Gu D (2006) Expression of recombinant hybrid peptide cecropinA(1-8)-magainin2(1-12) in Pichia pastoris : purification and characterization. Protein Expr Purif 50:147-156
19. Johnson A (2003) The biology of mating in Candida albicans. Nat Rev Microbiol 1:106-116
20. Jones RN (2006) Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains. Clin Infect Dis 42:S13-S24
21. Ju H, Liang DC, Guo G (2003) Comparison of four methods to prepare Pichia genomic DNA for PCR. Tianjin Med J 31:270-272
22. Kaplan CW, Sim JH, Shah KR, Kolesnikova-Kaplan A, Shi WY, Eckert R (2011) Selective membrane disruption: mode of action of C16G2, a specifically targeted antimicrobial peptide. Antimicrob Agents Chemother 55:3446-3452
23. Kim JM, Jang SA, Yu BJ, Sung BH, Cho JH, Kim SC (2008) High-level expression of an antimicrobial peptide histonin as a natural form by multimerization and furin-mediated cleavage. Appl Microbiol Biotechnol 78:123-130
24. Kim HK, Thammavongsa V, Schneewind O, Missiakas D (2012) Recurrent infections and immune evasion strategies of Staphylococcus aureus. Curr Opin Microbiol 15:92-99
25. Köck R, Becker K, Cookson B, van Gemert-Pijnen J, Harbarth S, Kluytmans J, Mielke M, Peters G, Skov R, Struelens M (2010) Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill 15:19688
26. Li L, Guo L, Lux R, Eckert R, Yarbrough D, He J, Anderson M, Shi W (2010) Targeted antimicrobial therapy against Streptococcus mutans establishes protective non-cariogenic oral biofilms and reduces subsequent infection. Int J Oral Sci 2:66-73
27. Lu X, Wan L, Yang H, Zhang J, Li S, Kang M, Li Y, Cheng J (2006) Fusion of fungicidal peptide dhvar4 to enterococcal peptide pheromone increases its bactericidal activity against Enterococcus faecalis. Chem Biol Drug Des 68:220-224
28. Mai J, Tian XL, Gallant JW, Merkley N, Biswas Z, Syvitski R, Douglas SE, Ling J, Li YH (2011) A novel target-specific, salt-resistant antimicrobial peptide against the cariogenic pathogen Streptococcus mutans. Antimicrob Agents Chemother 55:5205-5213
29. Marr AK, Gooderham WJ, Hancock REW (2006) Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol 6:468-472
30. Mygind PH, Fischer RL, Schnorr KM, Hansen MT, Sönksen CP, Ludvigsen S, Raventós D, Buskov S, Christensen B, De Maria L, Taboureau O, Yaver D, Elvig-Jørgensen SG, Sørensen MV, Christensen BE, Kjærulff S, Frimodt-Moller N, Lehrer RI, Zasloff M, Kristensen HH (2005) Plectasin is a peptide antibiotic with therapeutic potential froma saprophytic fungus. Nature 437:975-980
31. Neoh HM, Hori S, Komatsu M, Oguri T, Takeuchi F, Cui L, Hiramatsu K (2007) Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections. Ann Clin Microbiol Antimicrob 6:1-6
32. Neu HC (1992) The crisis in antibiotic resistance. Science 257:1064-1073
33. Otto M (2004) Quorum-sensing control in Staphylococci-a target for antimicrobial drug therapy? FEMS Microbiol Lett 241:135-141
34. Otto M (2012) Methicillin-resistant Staphylococcus aureus infection is associated with increased mortality. Future Microbiol 7:189-191
35. Park Y, Park SN, Park SC, Shin SO, Kim JY, Kang SJ, Kim MH, Jeong CY, Hahm KS (2006) Synergism of Leu-Lys rich antimicrobial peptides and chloramphenicol against bacterial cells. Biochim Biophys Acta 1764:24-32
36. Perron GG, Zasloff M, Bell G (2006) Experimental evolution of resistance to an antimicrobial peptide. P Roy Soc B-Biol Sci 273:251-256
37. Qiu XQ, Wang H, Lu XF, Zhang J, Li SF, Cheng G, Wan L, Yang L, Zuo JY, Zhou YQ, Wang HY, Cheng X, Zhang SH, Ou ZR, Zhong ZC, Cheng JQ, Li YP, Wu GY (2003) An engineered multidomain bactericidal peptide as a model for targeted antibiotics against specific bacteria. Nat Biotechnol 21:1480-1485
38. Qiu XQ, Zhang J, Wang H, Wu GY (2005) A novel engineered peptide, a narrow-spectrum antibiotic, is effective against vancomycin-resistant Enterococcus faecalis . Antimicrob Agents Chemother 49:1184-1189
39. Sader HS, Becker HK, Moet GJ, Jones RN (2010) Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 μg/mL isolated in the United States and European hospitals (2006-2008). Diagn Microbiol Infec Dis 66:329-331
40. Schägger H (2006) Tricine-SDS-PAGE. Nat Protoc 1:16-22
41. Schneider T, Kruse T, Wimmer R, Wiedemann I, Sass V, Pag U, Jansen A, Nielsen AK, Mygind PH, Raventos DS, Neve S, Ravn B, Bonvin AMJJ, De Maria L, Andersen AS, Gammelgaard LK, Sahl HG, Kristensen HH (2010) Plectasin, a fungal defensin, targets the bacterial cell wall precursor lipid II. Science 328:1168-1172
42. Skosyrev VS, Kulesskiy EA, Yakhnin AV, Temirov YV, Vinokurov LM (2003) Expression of the recombinant antibacterial peptide sarcotoxin IA in Escherichia coli cells. Protein Expr Purif 28:350-356
43. Soriano A, Marco F, Martínez JA, Pisos E, Almela M, Dimova VP, Alamo D, Ortega M, Lopez J, Mensa J (2008) Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 46:193-200
44. Tian ZG, Dong TT, Teng D, Yang YL, Wang JH (2009a) Design and characterization of novel hybrid peptides from LFB15(W4,10), HP (2-20), and cecropin A based on structure parameters by computer-aided method. Appl Microbiol Biotechnol 82:1097-1103
45. Tian ZG, Dong TT, Yang YL, Teng D, Wang JH (2009b) Expression of antimicrobial peptide LH multimers in Escherichia coli C43 (DE3). Appl Microbiol Biotechnol 83:143-149
46. van Leeuwen W, van Nieuwenhuizen W, Gijzen C, Verbrugh H, van Belkum A (2000) Population studies of methicillin-resistant and-sensitive Staphylococcus aureus strains reveal a lack of variability in the agrD gene, encoding a staphylococcal autoinducer peptide. J Bacteriol 182:5721-5729
47. Wang Y, Jiang Y, Gong T, Cui X, Li W, Feng Y, Wang B, Jiang Z, Li M (2010) High-level expression and novel antifungal activity of mouse beta defensin-1 mature peptide in Escherichia coli. Appl Biochem Biotechnol 160:213-221
48. Yacoby I, Benhar I (2007) Targeted anti bacterial therapy. Infect Disord Drug Targets 7:221-229
49. Yang Y, Teng D, Zhang J, Tian Z, Wang S, Wang J (2011) Characterization of recombinant plectasin: solubility, antimicrobial activity and factors that affect its activity. Process Biochem 46:1050-1055
50. Yeaman M, Yount N (2003) Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55:27-55
51. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415:389-395
52. Zhang J, Yang Y, Teng D, Tian Z, Wang S, Wang J (2011) Expression of plectasin in Pichia pastoris and its characterization as a new antimicrobial peptide against Staphyloccocus and Streptococcus. Protein Expr Purif 78:189-196